CD07743

· Galderma R&D

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD07743, covering 2020-05-01 to 2020-05-01. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET) [Phase 3]